Cannabis Use on the Rise: Should Employers Update Drug Policies?
In recent years, cannabis use has become increasingly prevalent in the United States. According to a report from the U.S. Department of Health, over 64 million Americans aged 12 and above used marijuana in 2024, representing a 19% increase since 2021. This growing trend is not limited to one region, as states like New Jersey have legalized recreational use, making it easily accessible to residents. In contrast, Pennsylvania restricts cannabis use to medical purposes only.
The widespread use of cannabis has significant implications for employers, particularly in terms of drug policies. Currently, cannabis is classified as a Schedule I controlled substance by the federal government. However, efforts are underway to reclassify it to Schedule III, which could lead to even greater acceptance and use of the substance.
As cannabis use becomes more common, employers are being forced to reevaluate their drug policies. With the predicted growth in popularity, should cannabis be included in employee testing and screening procedures? This question has sparked debate among HR professionals, as they weigh the benefits of maintaining strict policies against the need to accommodate the changing attitudes towards cannabis use.
The answer to this question is not straightforward, as it depends on various factors, including the type of workplace, job requirements, and local laws. While some argue that cannabis use should be treated similarly to other drugs, others believe that its unique properties and potential benefits warrant a more nuanced approach.
Ultimately, employers must carefully consider the implications of cannabis use in the workplace and develop policies that balance the needs of employees with the demands of the job. As the debate continues, one thing is clear: the rise of cannabis use is a trend that employers cannot ignore.
